financetom
Business
financetom
/
Business
/
IonQ Partners With Hamamatsu Photonics' Unit to Acquire Laser Systems; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IonQ Partners With Hamamatsu Photonics' Unit to Acquire Laser Systems; Shares Rise
Nov 9, 2024 12:25 PM

12:44 PM EST, 11/07/2024 (MT Newswires) -- IonQ ( IONQ ) shares were up 36% in recent Thursday trading after the company said it partnered with Hamamatsu Photonics' NKT Photonics unit to acquire advanced laser systems.

NKT Photonics will provide three prototype optical subsystems by 2025 to support the commercialization of IonQ's ( IONQ ) data center-ready quantum systems, including the IonQ Tempo and future barium-based computers, the company said.

The partnership will support IonQ ( IONQ ) in creating quantum computers that can easily fit into modern data centers, with NKT Photonics' fiber laser technology offering advantages in cost, performance and design, it added.

Financial details were not disclosed.

Price: 22.37, Change: +5.92, Percent Change: +35.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Oct 7, 2025
BRUSSELS (Reuters) -Candy and snacks giant Mars' $36 billion bid to acquire Pringles maker Kellanova ( K ) is set to clear a major hurdle by winning unconditional European Union antitrust approval, three people with direct knowledge of the matter said. The deal, among the biggest in the sector, would bring under one roof brands ranging from M&Ms, Snickers and...
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Oct 7, 2025
07:21 AM EDT, 10/07/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that data from its phase 3 open-label extension study showed that its drug Omvoh, or mirikizumab-mrkz, achieved sustained clinical, endoscopic and steroid-free remission over four years in patients with moderate to severely active ulcerative colitis. After four years of treatment, the company said that 78% of...
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Oct 7, 2025
07:23 AM EDT, 10/07/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Tuesday the US Food and Drug Administration has indicated openness to a biologics license application submission for accelerated approval of its LX2006 candidate for the treatment of Friedreich ataxia cardiomyopathy. The submission will include interim clinical data from ongoing phase I/II studies of LX2006 pooled with new...
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Oct 7, 2025
BRUSSELS, Oct 7 (Reuters) - Candy and snacks giant Mars' $36 billion bid to acquire Pringles maker Kellanova ( K ) is set to clear a major hurdle by winning unconditional European Union antitrust approval, three people with direct knowledge of the matter said. The deal, among the biggest in the sector, would bring under one roof brands ranging from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved